Journal of Clinical Oncology , 0732-183X

Journal

1 - 120 out of 120Page size: 500

Publications

  1. 2020
  2. E-pub ahead of print

    Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia

    Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , Naeem Khan & Sylvie Freeman, 29 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 12 p., JCO2002308.

    Research output: Contribution to journal › Article › peer-review

  3. E-pub ahead of print

    Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

    Sylvie Freeman, 23 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO2001170

    Research output: Contribution to journal › Article › peer-review

  4. E-pub ahead of print

    Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study

    Aneel Bhangu, 6 Oct 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 14 p., JCO2001933.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies

    Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia

    Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.

    Research output: Contribution to journal › Editorial

  8. Published

    ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

    Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2019
  10. Published

    Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

    Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract › peer-review

  12. Published

    Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

    Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008

    & 22 others, , Keith Wheatley, 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.

    Research output: Contribution to journal › Article › peer-review

  14. 2018
  15. E-pub ahead of print

    High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008

    6 Sep 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 16 p.

    Research output: Contribution to journal › Article › peer-review

  16. E-pub ahead of print

    Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

    Keith Wheatley, 28 Aug 2018, (E-pub ahead of print) In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  17. E-pub ahead of print

    Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review

    Raoul Reulen, 6 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 36, 9 p.

    Research output: Contribution to journal › Article › peer-review

  18. E-pub ahead of print

    Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer

    Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049

    Research output: Contribution to journal › Abstract › peer-review

  19. Published

    Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations

    Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial

    Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.

    Research output: Contribution to journal › Article › peer-review

  21. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , Daniel Rea, 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journal › Article › peer-review

  22. Published

    Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

    9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.

    Research output: Contribution to journal › Abstract › peer-review

  23. 2017
  24. Published

    Improving outcomes in high-risk Myelodysplasia: Festina Lente

    Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812

    Research output: Contribution to journal › Editorial › peer-review

  25. E-pub ahead of print

    Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

    Gary Middleton, 27 Feb 2017, (E-pub ahead of print) In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  26. Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials

    20 Feb 2017, In: Journal of Clinical Oncology . 35, 6, p. 622-628 7 p.

    Research output: Contribution to journal › Article › peer-review

  27. Published

    Randomized prospective biomarker trial of ERCC1 for comparing platinum and nonplatinum therapy in advanced non-small-cell lung cancer: ERCC1 Trial (ET)

    Gary Middleton, David Ferry & 3 others, , 1 Feb 2017, In: Journal of Clinical Oncology . 35, 4, p. 402-411 10 p.

    Research output: Contribution to journal › Article › peer-review

  28. 2016
  29. Published

    Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study

    Raoul Reulen, Emma Lancashire & Michael Hawkins, 20 May 2016, In: Journal of Clinical Oncology . 34, 15, p. 1772-1779

    Research output: Contribution to journal › Article › peer-review

  30. 2015
  31. Published

    Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: a phase III, randomized, double-blind, placebo-controlled study

    Hisham Mehanna & 5 others, , 10 Dec 2015, In: Journal of Clinical Oncology . 33, 35, p. 4202-4209

    Research output: Contribution to journal › Article › peer-review

  32. Published

    Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

    Charles Craddock, 1 Oct 2015, In: Journal of Clinical Oncology . 33, 28, p. 3144-3151 10 p.

    Research output: Contribution to journal › Article › peer-review

  33. Published

    Collaborative Research in Childhood Cancer Survivorship: The Current Landscape

    Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-3064 10 p.

    Research output: Contribution to journal › Review article › peer-review

  34. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journal › Article › peer-review

  35. Published

    Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

    Rich Fox, 20 Feb 2015, Journal of Clinical Oncology , 33, 6, p. 550 558 p.

    Research output: Contribution to specialist publication › Article

  36. 2014
  37. Published

    Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

    Daniel Rea, 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958

    Research output: Contribution to journal › Article › peer-review

  38. Published

    Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial

    Keith Wheatley, 10 Aug 2014, In: Journal of Clinical Oncology . 32, 23, p. 2440-8 9 p.

    Research output: Contribution to journal › Article › peer-review

  39. Published

    Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): An individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts).

    Natalie Rowland & Keith Wheatley, 20 May 2014, In: Journal of Clinical Oncology . 32, 15_suppl, 9067.

    Research output: Contribution to journal › Article › peer-review

  40. Published

    Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

    Claire Palles & 24 others, , David Kerr & Ian Tomlinson, 1 Apr 2014, In: Journal of Clinical Oncology . 32, 10, p. 1031-1039 9 p.

    Research output: Contribution to journal › Article › peer-review

  41. 2013
  42. Published

    Reply to K.I. Pritchard

    Daniel Rea, 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.

    Research output: Contribution to journal › Article › peer-review

  43. Published

    Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia

    Sylvie Freeman, Robert Hills, Nov 2013, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article › peer-review

  44. Published

    Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial

    Robert Hills, Keith Wheatley, 20 Sep 2013, In: Journal of Clinical Oncology . 31, 27, p. 3360-8 9 p.

    Research output: Contribution to journal › Article › peer-review

  45. Published

    Is uterine serous carcinoma a part of hereditary breast cancer syndrome

    Sudha Sundar, 10 Sep 2013, In: Journal of Clinical Oncology . 31, 26

    Research output: Contribution to journal › Article › peer-review

  46. Published

    Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

    Mark Drayson, 10 Jul 2013, In: Journal of Clinical Oncology . 31, 20, p. 2540-7 8 p.

    Research output: Contribution to journal › Article › peer-review

  47. Published

    Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

    Pamela Kearns, 1 Jul 2013, In: Journal of Clinical Oncology . 31, 19, p. 2460-2468 9 p.

    Research output: Contribution to journal › Article › peer-review

  48. Published

    Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)

    Lucinda Billingham, Stuart Collins, Emilio Porfiri, 20 Jun 2013, In: Journal of Clinical Oncology . 31, 18_suppl, p. LBA5000

    Research output: Contribution to journal › Article › peer-review

  49. Published

    Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis

    Daniel Rea, 20 Jun 2013, In: Journal of Clinical Oncology. 31, 18, p. 2257-2264 8 p.

    Research output: Contribution to journal › Article › peer-review

  50. Published

    Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone

    Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.

    Research output: Contribution to journal › Abstract › peer-review

  51. Published

    Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial

    Keith Wheatley, 20 May 2013, In: Journal of Clinical Oncology . 31, suppl 15, abstr 10031.

    Research output: Contribution to journal › Article › peer-review

  52. Published

    Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission

    Robert Hills, Keith Wheatley, 1 Apr 2013, In: Journal of Clinical Oncology . 31, 10, p. 1293-301 9 p.

    Research output: Contribution to journal › Article › peer-review

  53. Published

    Muscle invasive bladder cancer in the elderly: Treatment and prognosis in a prospective cohort study

    Tom Wright, Adam Devall, Sarah Pirrie, Lucinda Billingham, KK Cheng, Rik Bryan, 20 Feb 2013, In: Journal of Clinical Oncology . 31, 6_suppl, p. 275

    Research output: Contribution to journal › Article › peer-review

  54. Published

    Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

    Dickens Pratt & 1 others, , 20 Jan 2013, In: Journal of Clinical Oncology. 31, 3, p. 301-307

    Research output: Contribution to journal › Article › peer-review

  55. 2012
  56. Published

    Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study

    Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.

    Research output: Contribution to journal › Article › peer-review

  57. Published

    Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia

    Robert Hills, Sylvie Freeman, Charles Craddock, Keith Wheatley, 2012, In: Journal of Clinical Oncology . 30, 32, p. 3924-31 8 p.

    Research output: Contribution to journal › Article › peer-review

  58. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article › peer-review

  59. 2011
  60. Published

    Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.

    Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article

  61. Published

    Health Care Use of Long-Term Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study

    Raoul Reulen, Andrew Toogood, Emma Lancashire & Michael Hawkins, 26 Sep 2011, In: Journal of Clinical Oncology. 29, 31, p. 4181-4188 8 p.

    Research output: Contribution to journal › Article › peer-review

  62. Published

    Quantification of Hormone Receptors to Guide Adjuvant Therapy Choice in Early Breast Cancer: Better Methods Required for Improved Utility

    Daniel Rea, 1 Sep 2011, In: Journal of Clinical Oncology. 29, 27, p. 3715-3716 2 p.

    Research output: Contribution to journal › Article

  63. Published

    Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

    Kelly Handley, Laura Magill, Richard Gray, 1 Apr 2011, In: Journal of Clinical Oncology. 29, 10, p. 1261-1270 10 p.

    Research output: Contribution to journal › Article

  64. Published

    Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial.

    Toon Brookes, Lucinda Billingham & Daniel Rea, 21 Mar 2011, In: Journal of Clinical Oncology. 29, 12, p. 1531-1538

    Research output: Contribution to journal › Article

  65. Published

    Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Robert Hills & Keith Wheatley, 1 Feb 2011, In: Journal of Clinical Oncology. 29, 4, p. 369-377 9 p.

    Research output: Contribution to journal › Article

  66. Published

    Outcome in Renal AL Amyloidosis After Chemotherapy

    Jo Bradwell, 1 Feb 2011, In: Journal of Clinical Oncology. 29, 6, p. 674-681 8 p.

    Research output: Contribution to journal › Article

  67. Published

    Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

    Gary Middleton, 2011, In: Journal of Clinical Oncology . 29, 19, p. 2667-74 8 p.

    Research output: Contribution to journal › Article › peer-review

  68. 2010
  69. Published

    Population-Based Risks of CNS Tumors in Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study.

    Aliki Taylor, Emma Lancashire, Raoul Reulen & Michael Hawkins, 15 Nov 2010, In: Journal of Clinical Oncology. 28, 36, p. 5287-5293

    Research output: Contribution to journal › Article

  70. Published

    Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial

    Simon Grumett, Michael Langman, 1 Oct 2010, In: Journal of Clinical Oncology. 28, 30, p. 4575-4580 6 p.

    Research output: Contribution to journal › Article

  71. Published

    Novel uses of coded data in clinical trials

    Stuart Collins & Nicholas James, 31 May 2010, In: Journal of Clinical Oncology . 28, no. 15_suppl, p. 6143 6143 p., suppl.6143.

    Research output: Contribution to journal › Abstract › peer-review

  72. Published

    Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12.

    Robert Hills, Keith Wheatley, 3 May 2010, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article

  73. Published

    Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer

    Michael Hawkins, 10 Mar 2010, In: Journal of Clinical Oncology. 28, 8, p. 1308-1315 8 p.

    Research output: Contribution to journal › Article

  74. Published

    How Should We Prevent Hematologic Relapse of Acute Promyelocytic Leukemia? Reply

    Keith Wheatley, 1 Feb 2010, In: Journal of Clinical Oncology. 28, 4, p. E63-E64

    Research output: Contribution to journal › Article

  75. 2009
  76. Published

    Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial.

    Robert Hills & Keith Wheatley, 28 Dec 2009, In: Journal of Clinical Oncology. 28, 4, p. 586-595 10 p.

    Research output: Contribution to journal › Article

  77. Published

    Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al

    Keith Wheatley, 1 Dec 2009, In: Journal of Clinical Oncology. 27, 34, p. E222-E223

    Research output: Contribution to journal › Article

  78. Published

    Survival After Second Primary Neoplasms of the Brain or Spinal Cord in Survivors of Childhood Cancer: Results From the British Childhood Cancer Survivor Study

    Aliki Taylor, Raoul Reulen, Emma Lancashire & Michael Hawkins, 1 Dec 2009, In: Journal of Clinical Oncology. 27, 34, p. 5781-5787 7 p.

    Research output: Contribution to journal › Article

  79. Published

    Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

    Deborah Stocken, 20 Nov 2009, In: Journal of Clinical Oncology. 27, 33, p. 5513-5518 6 p.

    Research output: Contribution to journal › Article

  80. Published

    Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy.

    Keith Wheatley, 8 Jun 2009, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article

  81. Published

    Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy

    Keith Wheatley, 1 Jun 2009, In: Journal of Clinical Oncology. 27, 18, p. 2991-2999 9 p.

    Research output: Contribution to journal › Article

  82. Published

    Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

    Dickens Pratt, Robert Hills, 10 Feb 2009, In: Journal of Clinical Oncology. 27, 5, p. 763-769 7 p.

    Research output: Contribution to journal › Article

  83. Published

    Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

    Nicholas James, 2009, In: Journal of Clinical Oncology . 27, 32, p. 5431-8 8 p.

    Research output: Contribution to journal › Article › peer-review

  84. Published

    Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group

    Gary Middleton, 2009, In: Journal of Clinical Oncology . 27, 23, p. 3786-93 8 p.

    Research output: Contribution to journal › Article › peer-review

  85. 2008
  86. Published

    New Utility of an Old Marker: Serial  -Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

    Philip Johnson, 15 Dec 2008, In: Journal of Clinical Oncology. 27, 3, p. 446-452 7 p.

    Research output: Contribution to journal › Article

  87. Published

    Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2

    Eamonn Maher, Jonathan Mathers, 1 Jul 2008, In: Journal of Clinical Oncology. 26, 20, p. 3434-3439 6 p.

    Research output: Contribution to journal › Article

  88. Published

    EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

    Gary Middleton, 2008, In: Journal of Clinical Oncology . 26, 14, p. 2311-9 9 p.

    Research output: Contribution to journal › Article › peer-review

  89. 2007
  90. Published

    Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.

    Natalie Rowland, Becky Harrison & Keith Wheatley, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5426-34 9 p.

    Research output: Contribution to journal › Article

  91. Published

    Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion

    Judy Powell, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5448-57 10 p.

    Research output: Contribution to journal › Article

  92. Published

    Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy

    Lucinda Billingham & Neil Steven, 20 Oct 2007, In: Journal of Clinical Oncology. 25, 30, p. 4821-4828 8 p.

    Research output: Contribution to journal › Article

  93. Published

    End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

    Richard Gray, 10 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4569-4574 6 p.

    Research output: Contribution to journal › Article

  94. Published

    Does adjuvant vaccine therapy really have activity in malignant melanoma?

    Keith Wheatley, Natalie Rowland, 1 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4693-4693 1 p.

    Research output: Contribution to journal › Article

  95. Published

    Role of Lymphangiogenesis in Cancer

    Sudha Sundar, 13 Aug 2007, In: Journal of Clinical Oncology. 25, 27, p. 4298-4307 10 p.

    Research output: Contribution to journal › Article

  96. Published

    The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: the updated definitive joint analysis

    Sarah Bathers, 20 Jun 2007, In: Journal of Clinical Oncology . 25, 18 suppl, 1 p., 534.

    Research output: Contribution to journal › Abstract

  97. Published

    Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study

    Michael Hawkins, 11 Jun 2007, In: Journal of Clinical Oncology. 25, p. 2833-2839 7 p.

    Research output: Contribution to journal › Article

  98. Published

    Randomised trial of exercise therapy in women treated for breast cancer

    Amanda Daley & Andrea Roalfe, 1 May 2007, In: Journal of Clinical Oncology. 25, p. 1713-1721 9 p.

    Research output: Contribution to journal › Article

  99. Published

    Suicide among survivors of childhood cancer

    Michael Hawkins, 1 Jan 2007, In: Journal of Clinical Oncology. 2007, 25, p. 731-732 2 p.

    Research output: Contribution to journal › Article

  100. Published

    Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamise (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT) 40th Annual American Society of Slinical Oncology meeting. New Orleans, Louisiana USA June 2004

    Sarah Bathers, 1 Jan 2007, In: Journal of Clinical Oncology . 22 (14), p. 595S

    Research output: Contribution to journal › Article

  101. 2006
  102. Published

    Problems with up-front randomization in clinical trials

    Keith Wheatley, Robert Hills, 6 Nov 2006, In: Journal of Clinical Oncology. 24, p. 5471-5472 2 p.

    Research output: Contribution to journal › Letter

  103. Published

    Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy

    Beth Grunfeld, 2006, In: Journal of Clinical Oncology . 24, 7, p. 1090-8 9 p.

    Research output: Contribution to journal › Article › peer-review

  104. 2005
  105. Published

    Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia

    Charles Craddock, Gulnaz Begum, 28 Nov 2005, In: Journal of Clinical Oncology. 23, 36, p. 9387-9393 7 p.

    Research output: Contribution to journal › Article › peer-review

  106. Published

    Early mortality after diagnosis of multiple myeloma: Analysis of patients endered onto the United Kingdom Medical Research Council trials between 1980 and 2002

    Gulnaz Begum, Janet Dunn & Mark Drayson, 28 Nov 2005, In: Journal of Clinical Oncology. 23, p. 9219-9226 8 p.

    Research output: Contribution to journal › Article

  107. Published

    An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results

    Philip Johnson, 1 Nov 2005, In: Journal of Clinical Oncology. 23, p. 8041-8047 7 p.

    Research output: Contribution to journal › Article

  108. Published

    Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies

    Richard Gray, 31 Oct 2005, In: Journal of Clinical Oncology. 23, p. 8664-8670 7 p.

    Research output: Contribution to journal › Article

  109. Published

    Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of haematologic malignancies: An individual patient data meta-analysis of nine randomised trials

    Keith Wheatley & Robert Hills, 6 Jun 2005, In: Journal of Clinical Oncology. 23, p. 5074-5087 14 p.

    Research output: Contribution to journal › Article

  110. Published

    Adjuvant interferon therapy for melanoma

    Keith Wheatley, Natalie Rowland, 7 Feb 2005, In: Journal of Clinical Oncology. 23, p. 2431 1 p.

    Research output: Contribution to journal › Letter

  111. Published

    Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group

    Christopher Poole, 7 Feb 2005, In: Journal of Clinical Oncology. 23, 9, p. 1859-1866 8 p.

    Research output: Contribution to journal › Article

  112. Published

    Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic leukaemia once treatment is initiated

    Dickens Pratt, 31 Jan 2005, In: Journal of Clinical Oncology. 23, p. 1514-1521 8 p.

    Research output: Contribution to journal › Article

  113. Published

    WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs)

    Annie Young, Gulnaz Begum, Lucinda Billingham, Daniel Rea, Keith Wheatley, 1 Jan 2005, In: Journal of Clinical Oncology. 23, p. 16S

    Research output: Contribution to journal › Abstract

  114. 2004
  115. Published

    Malignant breast tumours following radiotherapy for a first cancer during childhood

    Michael Hawkins, 31 Dec 2004, In: Journal of Clinical Oncology. 23, p. 197-204 8 p.

    Research output: Contribution to journal › Article

  116. Published

    Virus directed enzyme prodrug therapy: Intratumoural administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer

    Daniel Palmer, Vivien Mautner, Stefan Hubscher, Seran Hill, Peter Searle, Lawrence Young, Nicholas James, 29 Mar 2004, In: Journal of Clinical Oncology. 22, p. 1546-1552 7 p.

    Research output: Contribution to journal › Article

  117. Published

    Azacitidine induces demethylation of the Epstein-Barr virus genome in tumours

    Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 1373-1381 9 p.

    Research output: Contribution to journal › Article

  118. Published

    Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy

    Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 927-934 8 p.

    Research output: Contribution to journal › Article

  119. Published

    Pathologic complete response and survival advantage in esophageal cancer: Old news

    Deborah Stocken, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 2513-2514 2 p.

    Research output: Contribution to journal › Article

  120. Published

    Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA

    Philip Johnson, 1 Jan 2004, In: Journal of Clinical Oncology. 22, p. 3053-3060 8 p.

    Research output: Contribution to journal › Article

  121. Published

    A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer

    Gary Middleton, 2004, In: Journal of Clinical Oncology. 22, 15, p. 3023-31 9 p.

    Research output: Contribution to journal › Article › peer-review

  122. 2003
  123. Published

    Adjuvant interferon in high-risk melanoma: The AIM HIGH Study-United Kingdom Coordinating Committee on cancer research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma

    Keith Wheatley, Natalie Rowland, 2 Dec 2003, In: Journal of Clinical Oncology. 22, p. 53-61 9 p.

    Research output: Contribution to journal › Article

  124. Published

    Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: Pathologic complete response induced by chemotherapy leads to long-term survival

    Deborah Stocken, 24 Sep 2003, In: Journal of Clinical Oncology. 21, p. 4009-4015 7 p.

    Research output: Contribution to journal › Article

  125. Published

    Older age is an adverse prognostic factor in Stage I favourite histology Wilms tumour treated with Vincristine mono-chemotherapy: A UK Children's Cancer Study group Study

    Sep 2003, In: Journal of Clinical Oncology. 21, 17, p. 3269-3275 7 p.

    Research output: Contribution to journal › Article › peer-review

  126. Published

    Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma

    Philip Johnson, 15 Feb 2003, In: Journal of Clinical Oncology. 21, 4, p. 652-658 7 p.

    Research output: Contribution to journal › Article

  127. 2002
  128. Published

    Need for a quantitative meta-analysis of trials of adjuvant interferon in melanoma

    Keith Wheatley, Natalie Rowland, 1 Oct 2002, In: Journal of Clinical Oncology. 20, 19, p. 4120-4122 3 p.

    Research output: Contribution to journal › Letter

  129. Published

    Role of non-myeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies

    Alan Parker, Ronjon Chakraverty, Charles Craddock, 1 Oct 2002, In: Journal of Clinical Oncology. 20, 19, p. 4022-4031 10 p.

    Research output: Contribution to journal › Article › peer-review

  130. Published

    ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumours: Results of a Phase I trial

    Lisette Hammond, David Ferry, Phil Murray, 1 May 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-2250 11 p.

    Research output: Contribution to journal › Article

  131. Published

    Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a Phase III randomised trial

    Philip Johnson, 15 Apr 2002, In: Journal of Clinical Oncology. 20, 8, p. 2038-2044 7 p.

    Research output: Contribution to journal › Article

  132. Published

    Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin

    Leonard Seymour, David Ferry, Annie Young & David Kerr, 15 Mar 2002, In: Journal of Clinical Oncology. 20, 6, p. 1668-1676 9 p.

    Research output: Contribution to journal › Article

  133. Published

    Mutations of hMSH2 and hMLH1 in patients with suspected hereditary non-polyposis colorectal cancer (HNPCC)

    Emilio Porfiri, 1 Mar 2002, In: Journal of Clinical Oncology. 20, p. 1203-1208 6 p.

    Research output: Contribution to journal › Article

  134. Published

    Missense mismatch repair gene alterations, microsatellite instability and hereditary nonpolyposis colorectal cancer

    Emilio Porfiri, 1 Jan 2002, In: Journal of Clinical Oncology. 20, p. 3178-3179 2 p.

    Research output: Contribution to journal › Letter

  135. Published

    ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

    David Ferry, Phil Murray, 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-50 11 p.

    Research output: Contribution to journal › Article › peer-review

  136. 2001
  137. Published

    Ascertainment of the incidence of Beckwith-Wiedemann syndrome in the National Wilms Tumor Study Group

    Richard Grundy, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 2, p. 593-593 1 p.

    Research output: Contribution to journal › Article

  138. Published

    Marimastat as first line therapy for patients with unresectable pancreatic cancer - A randomised trial

    Simon Bramhall, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 15, p. 3447-3455 9 p.

    Research output: Contribution to journal › Article

  139. 2000
  140. Published

    Quality of life in non-small-cell lung cancer

    Lucinda Billingham, Apr 2000, In: Journal of Clinical Oncology . 18, 8, p. 1802

    Research output: Contribution to journal › Article › peer-review

  141. 1999
  142. Published

    Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

    Lucinda Billingham, David Ferry, Oct 1999, In: Journal of Clinical Oncology . 17, 10, p. 3188-94 7 p.

    Research output: Contribution to journal › Article › peer-review